139 related articles for article (PubMed ID: 11557291)
21. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
[TBL] [Abstract][Full Text] [Related]
22. A retrospective study of canine transmissible venereal tumour in Grenada, West Indies.
Schectman SJ; Khanam A; Walters MND; Kirwan E; Sylvester WR; Khan FA
Vet Med Sci; 2022 May; 8(3):1008-1012. PubMed ID: 35238497
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological study of canine transmissible venereal tumor (CTVT) in Brazil, 2000-2020.
Pimentel PAB; Oliveira CSF; Horta RS
Prev Vet Med; 2021 Dec; 197():105526. PubMed ID: 34740024
[TBL] [Abstract][Full Text] [Related]
24. Immunocharacterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 in canine transmissible venereal tumors.
Akkoc A; Nak D; Demirer A; Şimşek G
Biotech Histochem; 2017; 92(2):100-106. PubMed ID: 28296543
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and Management of an Oronasal Fistula Secondary to Nasal Transmissible Venereal Tumor in a Dog.
Thatcher G; Robat C; Bell C
J Vet Dent; 2020 Dec; 37(4):220-226. PubMed ID: 33719713
[TBL] [Abstract][Full Text] [Related]
26. Computer tomographic imaging in 4 dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype.
Ojeda J; Mieres M; Soto F; Arnes V; Paredes E; Navarrete M
J Vet Intern Med; 2018 May; 32(3):1172-1177. PubMed ID: 29604101
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a Canine Transmissible Venereal Tumour Cell Line with Tumour Immunity Capacity but Without Tumorigenic Property.
Zayas YR; Molina MAF; Guerra RT; Padilla CR
J Vet Res; 2019 Jun; 63(2):225-233. PubMed ID: 31276062
[TBL] [Abstract][Full Text] [Related]
28. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis.
Thomas R; Rebbeck C; Leroi AM; Burt A; Breen M
Chromosome Res; 2009; 17(7):927-34. PubMed ID: 19798471
[TBL] [Abstract][Full Text] [Related]
29. Sex disparity in oronasal presentations of canine transmissible venereal tumour.
Strakova A; Baez-Ortega A; Wang J; Murchison EP
Vet Rec; 2022 Sep; 191(5):e1794. PubMed ID: 35781651
[TBL] [Abstract][Full Text] [Related]
30. Detection of the tumour suppressor gene TP53 and expression of p53, Bcl-2 and p63 proteins in canine transmissible venereal tumour.
Stockmann D; Ferrari HF; Andrade AL; Cardoso TC; Luvizotto MC
Vet Comp Oncol; 2011 Dec; 9(4):251-9. PubMed ID: 22077405
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.
Chiang HC; Wang YS; Chou CH; Liao AT; Chu RM; Lin CS
BMC Vet Res; 2012 Nov; 8():216. PubMed ID: 23136963
[TBL] [Abstract][Full Text] [Related]
32. Analysis of canine transmissible veneral tumor genotypes using the D-loop region of mitochondrial DNA.
Bautista-Gómez LG; Martínez-Castañeda S; Córdova-Alarcón E; Vázquez-Chagoyán JC
Genes Genet Syst; 2011; 86(5):351-5. PubMed ID: 22362033
[TBL] [Abstract][Full Text] [Related]
33. Canine transmissible venereal tumor - From general to molecular characteristics: A review.
Faro TAS; de Oliveira EHC
Anim Genet; 2023 Feb; 54(1):82-89. PubMed ID: 36259378
[TBL] [Abstract][Full Text] [Related]
34. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
[TBL] [Abstract][Full Text] [Related]
35. Presence of Papillomavirus DNA sequences in the canine transmissible venereal tumor (CTVT).
Ayala-Díaz S; Jiménez-Lima R; Ramírez-Alcántara KM; Lizano M; Castro-Muñoz LJ; Reyes-Hernández DO; Arroyo-Ledezma J; Manzo-Merino J
PeerJ; 2019; 7():e7962. PubMed ID: 31667018
[TBL] [Abstract][Full Text] [Related]
36. Sequence analysis of canine LINE-1 elements and p53 gene in canine transmissible venereal tumor.
Choi YK; Kim CJ
J Vet Sci; 2002 Dec; 3(4):285-92. PubMed ID: 12825561
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth.
Pérez J; Day MJ; Mozos E
Vet Immunol Immunopathol; 1998 Jul; 64(2):133-47. PubMed ID: 9661263
[TBL] [Abstract][Full Text] [Related]
38. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
Mukaratirwa S; Gruys E
Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical evaluation of heat shock protein expression in normal canine nerve and peripheral nerve sheath tumours.
Romanucci M; Berardi I; Ciccarelli A; Bongiovanni L; Malatesta D; Oevermann A; Della Salda L
J Comp Pathol; 2013; 149(2-3):216-20. PubMed ID: 23348018
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer.
Strakova A; Ní Leathlobhair M; Wang GD; Yin TT; Airikkala-Otter I; Allen JL; Allum KM; Bansse-Issa L; Bisson JL; Castillo Domracheva A; de Castro KF; Corrigan AM; Cran HR; Crawford JT; Cutter SM; Delgadillo Keenan L; Donelan EM; Faramade IA; Flores Reynoso E; Fotopoulou E; Fruean SN; Gallardo-Arrieta F; Glebova O; Häfelin Manrique RF; Henriques JJ; Ignatenko N; Koenig D; Lanza-Perea M; Lobetti R; Lopez Quintana AM; Losfelt T; Marino G; Martincorena I; Martínez Castañeda S; Martínez-López MF; Meyer M; Nakanwagi B; De Nardi AB; Neunzig W; Nixon SJ; Onsare MM; Ortega-Pacheco A; Peleteiro MC; Pye RJ; Reece JF; Rojas Gutierrez J; Sadia H; Schmeling SK; Shamanova O; Ssuna RK; Steenland-Smit AE; Svitich A; Thoya Ngoka I; Vițălaru BA; de Vos AP; de Vos JP; Walkinton O; Wedge DC; Wehrle-Martinez AS; van der Wel MG; Widdowson SA; Murchison EP
Elife; 2016 May; 5():. PubMed ID: 27185408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
